Please assess the completion status of the following clinical trial:

Trial Title: Isolated Limb Infusion of Chemotherapy in Treating Patients With Melanoma or Soft Tissue Sarcoma of the Arm or Leg That Cannot Be Removed By Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
DISEASE CHARACTERISTICS:~* Histologically proven primary or recurrent, regional melanoma or soft tissue sarcoma that is not amenable to surgical resection~  * Majority (greater than 95%) of disease must be distal to the apex of the femoral triangle in the lower limb and the deltoid insertion in the upper limb~* Bidimensionally measurable disease in the extremity~* Patients with disease beyond the limb are eligible if their extremity disease requires palliative treatment in the judgment of their physician~PATIENT CHARACTERISTICS:~Age:~* Over 18~Performance status:~* Karnofsky 70-100%~Life expectancy:~* At least 6 months~Hematopoietic:~* WBC at least 3,000/mm\^3~Hepatic:~* Not specified~Renal:~* Creatinine less than 2.0 mg/dL~Cardiovascular:~* Must have palpable femoral/axillary, dorsalis pedis/popliteal, or radial pulses in the extremity to be treated~* No signs or symptoms of vascular insufficiency (no history of claudication or other ischemic peripheral vascular disease)~Other:~* Not pregnant or nursing~* Negative pregnancy test~* No other concurrent serious illness~* No severe diabetes~  * No prior extremity complications due to diabetes~PRIOR CONCURRENT THERAPY:~Biologic therapy~* Not specified~Chemotherapy~* Not specified~Endocrine therapy~* Not specified~Radiotherapy~* Not specified~Surgery~* Not specified~Other~* At least 4 weeks since prior antitumor therapy and recovered~* At least 2 weeks since prior antibiotics

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).